http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102131898-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-7014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6863 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2851 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2018-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102131898-B1 |
| titleOfInvention | Bispecific antibody targeting scf and galectin-1, and use thereof |
| abstract | The present invention relates to a composition for preventing or treating an angiogenesis-related disease and a dual target antibody targeting SCF (Stem Cell Factor) and Galectin-1. The present invention prevents or treats angiogenesis-related diseases comprising the antibody and a dual target antibody derived from a human monoclonal antibody capable of effectively inhibiting angiogenesis by simultaneously neutralizing SCF and galectin-1 involved in angiogenesis. It provides a pharmaceutical composition. The dual target antibody according to the present invention can effectively prevent or treat angiogenesis-related diseases that cause bleeding by neutralizing two targets involved in angiogenesis at the same time, thereby increasing the permeability of blood vessels through abnormal angiogenesis. |
| priorityDate | 2017-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 478.